Market Tracker

05/25 5:15pm ET

Depomed Inc (NASDAQ:DEPO)

6.34
Delayed Data
As of May 25
 -0.40 / -5.93%
Today’s Change
4.31
Today|||52-Week Range
11.27
-21.24%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close6.74
Today’s open6.71
Day’s range6.28 - 6.75
Volume841,349
Average volume (3 months)1,323,987
Market cap$461.6M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-12.41%
Earnings growth (this year)+74.47%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-16.49%
P/E ratioNM
Price/Sales1.33
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.02-0.42%
SVASinovac Biotech Ltd+0.05+0.66%
AVDLAvadel Pharmaceutica...+0.28+4.33%
TLGTTeligent Inc+0.02+0.73%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$0.17
Annual revenue (last year)$380.7M
Annual profit (last year)-$102.5M
Net profit margin-26.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Senior Vice President-Operations &
Business
Sean P. McKercher
Corporate headquarters
Newark, California

Forecasts